Reuters logo
BRIEF-Nicox gets license for three Insite Vision's ophthalmic therapeutics
February 2, 2015 / 6:47 AM / 3 years ago

BRIEF-Nicox gets license for three Insite Vision's ophthalmic therapeutics

Feb 2 (Reuters) - Nicox SA :

* Signs exclusive license agreement with InSite Vision for Azasite and Bromsite in Europe

* European regulatory filings for Azasite and Bromsite planned by Q1 2016

* Agreement grants Nicox exclusive rights to Azasite, Bromsite and Azasite Xtra in Europe, Middle East and Africa

* European Marketing Authorization Applications for Azasite and Bromsite to be filed by Q1 2016, first launch expected in late 2017 Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below